Product Information
KEVZARA 200 MG/1.14 ML SYRINGE is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $2066.4821 per ML under NDC 00024591001. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
200 mg/1.14mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024591001
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
1/1/2026
Active Ingredients
SARILUMABApproval Type
Biologic (BLA)
FDA Application
BLA761037On Market Since
5/22/2017
Pharmacological Classes
Price Statistics
The NADAC for KEVZARA 200 MG/1.14 ML SYRINGE has been published 28 times since Dec 17, 2025, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2066.4821 per ML |
|---|---|
| All-time high | $2066.4821 (Jun 24, 2026) |
| All-time low | $1949.5114 (Dec 17, 2025) |
| 52-week high | $2066.4821 |
| 52-week low | $1949.5114 |
| Median price | $2066.4821 |
| Average price | $2053.9495 |
| Largest weekly change | +6.0% (Jan 7, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of KEVZARA 200 MG/1.14 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for KEVZARA 200 MG/1.14 ML SYRINGE, manufactured by Sanofi-Aventis U.S. LLC, is $2066.4821 per ML (NDC 00024591001), effective Jun 24, 2026.
How has the price of KEVZARA 200 MG/1.14 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for KEVZARA 200 MG/1.14 ML SYRINGE has risen 6.0%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for KEVZARA 200 MG/1.14 ML SYRINGE?
Since Dec 17, 2025, the NADAC for KEVZARA 200 MG/1.14 ML SYRINGE has ranged from a low of $1949.5114 (Dec 17, 2025) to a high of $2066.4821 (Jun 24, 2026), with a median of $2066.4821 per ML.
Are there cheaper alternatives to KEVZARA 200 MG/1.14 ML SYRINGE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as KEVZARA 200 MG/1.14 ML SYRINGE, but none are currently priced below it.
Who manufactures KEVZARA 200 MG/1.14 ML SYRINGE?
KEVZARA 200 MG/1.14 ML SYRINGE (NDC 00024591001) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.